Literature DB >> 26277087

Antecubital vs Femoral Venous Access for Right Heart Catheterization: Benefits of a Flashback.

Vincent Roule1, Sabri Ailem2, Damien Legallois2, Ziad Dahdouh2, Thérèse Lognoné2, Emmanuel Bergot3, Gilles Grollier2, Paul Milliez2, Rémi Sabatier2, Farzin Beygui4.   

Abstract

BACKGROUND: Although rare, complications of right heart catheterization (RHC) are usually related to the access site. Antecubital venous access for RHC allows immediate ambulation and may reduce access-site complications, but data on this approach are scarce.
METHODS: Our study prospectively collected comprehensive data from consecutive RHCs performed at our academic center between February 2010 and August 2013. Demographic, procedural, and in-hospital outcomes were compared between patient groups defined by antecubital and femoral approaches.
RESULTS: A total of 1007 RHC procedures was performed; 895 (88.9%) were performed through an antecubital approach and 112 (11.1%) were performed through a femoral approach. Antecubital attempts were successful in 92.8% of the clinically eligible patients. The antecubital approach was associated with a shorter procedure duration and fluoroscopy time as well as a lower radiation dose (P < 0.001 for all) compared with femoral access. Radiation dose and fluoroscopy time were significantly reduced (P < 0.001 for both) when antecubital procedures were performed by experienced operators compared with trainees. Periprocedural complications occurred in 8 patients (0.8%) (leading to prolonged hospitalization in only 1 patient in the femoral group). Access-site hematoma occurred more frequently in the femoral group (P < 0.001).
CONCLUSIONS: An antecubital venous approach is a feasible alternative to femoral venous access for RHC. Shorter fluoroscopy time, lower radiation dose, and fewer access-site hematomas with this approach argue for its preferential use when possible and performed in an experienced centre.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26277087     DOI: 10.1016/j.cjca.2015.04.026

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Right heart catheterization procedures in patients with suspicion of pulmonary hypertension - experiences of a tertiary center.

Authors:  Maciej Grymuza; Katarzyna Małaczyńska-Rajpold; Stanisław Jankiewicz; Andrzej Siniawski; Marek Grygier; Przemysław Mitkowski; Marta Kałużna-Oleksy; Maciej Lesiak; Tatiana Mularek-Kubzdela; Aleksander Araszkiewicz
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-11-29       Impact factor: 1.426

2.  Brachial Approach As an Alternative Technique of Fibrin Sheath Removal for Implanted Venous Access Devices.

Authors:  Charalampos Sotiriadis; Steven David Hajdu; Francesco Doenz; Salah D Qanadli
Journal:  Front Surg       Date:  2017-04-10

3.  Feasibility and safety of the antecubital venous access for right heart catheterization in patients with pulmonary hypertension.

Authors:  Avital Avriel; Michael Kassirer; Avi Shimony; Gal Tsaban; Amir Bar-Shai; Miri Merkin; Gabriel Rosenstein; Doron Zahger; Jonathan Wiesen; Carlos Cafri
Journal:  Pulm Circ       Date:  2020-02-19       Impact factor: 3.017

4.  Feasibility and safety of catheter-directed thrombolysis via superficial cubital vein for the treatment of acute massive and submassive pulmonary embolism.

Authors:  Lovel Giunio; Mislav Lozo; Josip Andelo Borovac; Anteo Bradaric; Jaksa Zanchi; Dino Miric
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-12-29       Impact factor: 1.426

5.  Ultrasound-guided antecubital vein approach for right heart catheterisation in a Brazilian tertiary centre.

Authors:  Felipe Homem Valle; Rodrigo Vugman Wainstein; Bruno Silva Matte; Sandro Cadaval Gonçalves; Luiz Carlos C Bergoli; Ana Maria Rocha Krepsky; Fernando Pivatto Junior; Gustavo Neves de Araujo; Guilherme Pinheiro Machado; Marco Vugman Wainstein
Journal:  Open Heart       Date:  2020-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.